News & Events

Vaping 101: Kits, Pods, Devices, and Blister Packs

By: Ivy Tang, Product Safety Specialist, email Prefilled vaping pods, blister packaging, and starter kits all fall under the Vaping Products Labelling and Packaging Regulations. If you are selling vaping...

Registering a Hand Sanitizer in Canada

By: Sarah Calder, Regulatory Affairs Specialist, email Does a hand sanitizer require pre-approval in Canada before going to market? Hand sanitizers, hand sanitizing wipes, and antibacterial hand washes are regulated...

Chemical Regulatory Compliance Training

By: Kirsten Alcock, Manager of Product Safety, email Training. Where do you obtain it? What if you have something so specific that training is simply not available? There are plenty...

Does Your Product Contain Methylene Diphenyl Diisocyanates (MDI)?

By: Ivy Tang, Product Safety Specialist, email In May 2019, five MDIs (methylene diphenyl diisocyanates) were added to Schedule 1 of the List of Toxic Substances of the Canadian Environmental...

Health Canada’s Hazardous Substance Assessments

Last year at the Society for Chemical Hazard Classification (SCHC) conference in Washington DC, Kim Godard and Véronique Lalonde of Health Canada gave an update of where the Globally Harmonized...

Finalized Vaping Products Labeling and Packaging Regulations

By: Ivy Tang, Product Safety Specialist, email Final Vaping Products Labelling and Packaging Regulations (VPLPR) were published in the Canada Gazette, Part II on December 24th, 2019 and will come...

Consequences of a Non-Compliant Consumer Label

By: Ivy Tang, Product Safety Specialist, email Under the Canada Consumer Product Safety Act (CCPSA), it is prohibited to manufacture, import, or sell a consumer product that is dangerous to...

1, 4-Dioxane Essentially Banned in Cosmetics, Personal Care, and Cleaning Products in New York State

By: Joe McCarthy, Lab Service Manager/Senior Regulatory Affairs Specialist, email On December 9th, 2019, New York State Governor Andrew Cuomo signed into law legislation (S 4389B/A 6295A). This is “An...

Changing Establishment Licensing Fees for Human and Veterinary Drugs (DEL)

By: Teri Dickinson, Regulatory Affairs Group Manager, email Starting April 1, 2020, new Drug Establishment Licensing (DEL) fees will come into effect. DEL fees for human drugs and veterinary drugs...

Medical Device Establishment Licensing (MDEL) Post Market Cost Recovery

By: Teri Dickinson, Regulatory Affairs Group Manager, email Starting April 1, 2020, new medical device Establishment Licensing (MDEL) fees will come into effect. What can you expect to pay? [table...

Medical Devices: Evaluation and Right to Sell Fees

By: Teri Dickinson, Regulatory Affairs Group Manager, email Are you ready for Cost Recovery implementation coming into force on April 1, 2020? Starting April 1, 2020, new medical device submission...

Selling Consumer Products in Canada. What else do you need to consider?

By: Kirsten Alcock, Manager of Product Safety, email When selling a consumer product in Canada there are many factors to consider. Who is your market? Are you making any claims?...

Have Questions About Regulatory Compliance?

If you’re unsure what your next steps should be, check our frequently asked questions page or contact us today.